AR and prostate carcinoma: This relapse with progressive growth and metastasis of PC cancers depends on increased sensitivity of androgen receptors (AR) to castrate levels of androgens, androgen-independent activation of AR, or activation of signaling mechanisms that promote growth and survival of prostate cancer cells via AR-independent signaling pathways [2].